期刊文献+

459例住院患者替加环素临床应用分析

Clinical Application of Tigecycline in 459 Inpatients
下载PDF
导出
摘要 目的:探讨该院住院患者替加环素的使用合理性,以期为替加环素的临床应用提供合理化建议。方法:提取2018—2021年该院459例使用替加环素的住院患者的病例资料,根据《替加环素临床应用评价细则》、药品说明书及专家共识采取扣分制,分别对患者基本信息、用药情况、联合用药情况、病原学检查进行合理用药统计分析。结果:459例使用替加环素的住院患者年龄为28~103岁,平均用药疗程为(8.33±6.97)d;患者主要分布在重症医学科、急诊科及呼吸科;共检验出肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌等642株病原菌;替加环素主要用于治疗重症肺炎、皮肤及软组织感染、腹腔感染。不合理用药问题主要为特殊使用级抗菌药物缺少会诊过程、用法与用量不合理、适应证不适宜及病原学检验缺乏。结论:需进一步加强该院住院患者使用替加环素的管理,多学科协同管理,加强多科室业务学习,促进替加环素的临床合理应用。 OBJECTIVE:To probe into the application rationality of tigecycline in inpatients in the hospital,so as to provide reasonable suggestions for this clinical application of tigecycline.METHODS:Case data of 459 inpatients received tigecycline in the hospital from 2018 to 2021 were extracted,and point-deduction system was adopted to perform statistical analysis on rational medication in terms of patients'general information,medication situation,drug combined and etiological examination according to the Evaluation Rules for Clinical Application of Tigecycline,the dispensatory and the expert consensus.RESULTS:The 459 inpatients received tigecycline were aged 28 to 103 years old,and the average medication duration was(8.33±6.97)days;the patients were mainly distributed in the departments of intensive care medicine,emergency medicine and respiratory medicine;a total of 642 strains of pathogens were detected,including Klebsiella pneumoniae,Acinetobacter baumannii,and Pseudomonas aeruginosa.Tigecycline was mainly used in the treatment of severe pneumonia,skin and soft-tissue infections,and abdominal cavity infection.Problems of irrational medication mainly were the lack of consultation process for special-use antimicrobial drugs,irrational usage and dosage,inappropriate indications and the lack of pathogenetic testing.CONCLUSIONS:It is necessary to further strengthen the management of the application of tigecycline in inpatients and multidisciplinary management,reinforce multidisciplinary vocational learning,and promote the rational application of tigecycline.
作者 王志宏 张亚同 李朗 杨子贤 WANG Zhihong;ZHANG Yatong;LI Lang;YANG Zixian(Dept.of Pharmacy,Beijing Hospital,National Center for Geriatrics,Institute of Geriatrics,Chinese Academy of Medical Science,Beijing Key Laboratory of Assessment for Clinical Drugs Risk and Individual Application(Beijing Hospital),Beijing 100730,China)
机构地区 北京医院药学部
出处 《中国医院用药评价与分析》 2023年第12期1516-1520,共5页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 替加环素 合理用药 回顾性分析 Tigacycline Rational medication Retrospective analysis
  • 相关文献

参考文献5

二级参考文献60

  • 1赵培革,李艳华,徐俊萍,葛翠云.耐药鲍曼不动杆菌所致老年医院获得性肺炎相关因素[J].中国老年学杂志,2014,34(5):1360-1362. 被引量:11
  • 2邹国利.新型四环素类抗生素——丁甘米诺环素[J].国外医药(抗生素分册),2004,25(6):278-281. 被引量:7
  • 3汤国桢,施晓霞.第三代四环素品种介绍[J].上海医药,2005,26(3):137-138. 被引量:7
  • 4Boucher HW, Wennersten CB, Eliopoulos GM. In vitro activitiesof the glycylcycline GAR-936 against gram-positive bacteria[J].Antimicrob Agents Chemother, 2000, 44(8): 2225-2229.
  • 5Edlund C, Nord CE. In vitro susceptibility of anaerobic bacteriato GAR-936, a new glycylcycline[J]. Clin Microbiol Infect, 2000,6(3): 159-163.
  • 6Pankey GA. Tigecycline[J]. J Antimicrob Chemother, 2005,56(3): 470-480.
  • 7Mascarello M, Papa G, Arnez ZM, et al. Acute necrotizingpancreatitis related to tigecycline[J]. J Antimicrob Chemother,2012, 67(5): 1296-1297.
  • 8Prot-Labarthe S, Youdaren R, Benkerrou M, et al. Pediatric acutepancreatitis related to tigecycline[J]. Pediatr Infect Dis J, 2010,29(9): 890-891.
  • 9Gilson M, Moachon L, Jeanne L, et al. Acute pancreatitis relatedto tigecycline: case report and review of the literature[J]. Scand JInfect Dis, 2008, 40(8): 681-683.
  • 10Hung WY, Kogelman L, Volpe G, et al. Tigecycline-induced acutepancreatitis: case report and literature review[J]. Int J AntimicrobAgents, 2009, 34(5): 486-489.

共引文献234

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部